China's new pediatric drug guidance similar to U.S., aims to protect children
SHANGHAI – Six Chinese government agencies with authority over health matters, including the CFDA and the National Health and Family Planning Commission, have issued a joint opinion on pediatric drugs in an attempt to address the problem of medicine safety for children in China.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST